Consolidated Statements of Income - USD ($) shares in Millions, $ in Millions	12 Months Ended
	Apr. 26, 2024	Apr. 28, 2023	Apr. 29, 2022
Income Statement [Abstract]
Net sales	$ 32,364	$ 31,227	$ 31,686
Costs and expenses:
Cost of products sold, excluding amortization of intangible assets	11,216	10,719	10,145
Research and development expense	2,735	2,696	2,746
Selling, general, and administrative expense	10,736	10,415	10,292
Amortization of intangible assets	1,693	1,698	1,733
Restructuring charges, net	226	375	60
Certain litigation charges, net	149	(30)	95
Other operating expense (income), net	464	(131)	862
Operating profit	5,144	5,485	5,752
Other non-operating income, net	(412)	(515)	(318)
Interest expense, net	719	636	553
Income before income taxes	4,837	5,364	5,517
Income tax provision	1,133	1,580	456
Net income	3,705	3,784	5,062
Net income attributable to noncontrolling interests	(28)	(26)	(22)
Net income attributable to Medtronic	$ 3,676	$ 3,758	$ 5,039
Basic earnings per share (in dollars per share)	$ 2.77	$ 2.83	$ 3.75
Diluted earnings per share (in dollars per share)	$ 2.76	$ 2.82	$ 3.73
Basic weighted average shares outstanding (in shares)	1,327.7	1,329.8	1,342.4
Diluted weighted average shares outstanding (in shares)	1,330.2	1,332.8	1,351.4